Unknown

Dataset Information

0

Feasibility of MRI-guided large-core-needle biopsy of suspiscious breast lesions at 3 T.


ABSTRACT: The feasibility of large-core-needle magnetic resonance imaging (MRI)-guided breast biopsy at 3 T was assessed. Thirty-one suspicious breast lesions shown only by MRI were detected in 30 patients. Biopsy procedures were performed in a closed-bore 3-T clinical MR system on a dedicated phased-array breast coil with a commercially available add-on stereotactic biopsy device. Tissue sampling was technically successful in 29/31 (94%) lesions. Median lesion size (n = 29) was 9 mm. Histopathological analysis showed 19 benign lesions (66%) and one inconclusive biopsy result (3%). At follow-up of these lesions, 15 lesions showed no malignancy, no information was available in three patients and two lesions turned out to be malignant (one lesion at surgical excision 1 month after biopsy and one lesion at a second biopsy because of a more malignant enhancement curve at 12-months follow-up MRI). Nine biopsy results showed a malignant lesion (31%) which were all surgically removed. No complications occurred. MRI-guided biopsy at 3 T is a safe and effective method for breast biopsy in lesions that are occult on mammography and ultrasound. Follow-up MRI at 6 months after the biopsy should be performed in case of a benign biopsy result.

SUBMITTER: Peters NH 

PROVIDER: S-EPMC2691521 | biostudies-other | 2009 Jul

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC2409541 | biostudies-other
| S-EPMC2759967 | biostudies-literature
| S-EPMC7946110 | biostudies-literature
| S-EPMC3879952 | biostudies-literature
| S-EPMC4739716 | biostudies-other
| S-EPMC8217794 | biostudies-literature
| S-EPMC7125392 | biostudies-literature
| S-EPMC8466864 | biostudies-literature
| S-EPMC6731357 | biostudies-literature